HighTower Advisors, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 39 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$2,000
-95.0%
10,465
-0.5%
0.00%
Q1 2021$40,0000.0%10,516
+2.4%
0.00%
Q3 2019$40,000
-2.4%
10,2660.0%0.00%
Q2 2019$41,000
-10.9%
10,266
-4.6%
0.00%
Q1 2019$46,000
+17.9%
10,7660.0%0.00%
Q4 2018$39,000
-4.9%
10,7660.0%0.00%
Q3 2018$41,000
-2.4%
10,7660.0%0.00%
Q2 2018$42,000
+20.0%
10,7660.0%0.00%
Q1 2018$35,000
-16.7%
10,7660.0%0.00%
Q4 2017$42,0000.0%10,766
+4.9%
0.00%
Q3 2017$42,000
-2.3%
10,2660.0%0.00%
Q2 2017$43,000
-6.5%
10,266
-4.6%
0.00%
Q1 2017$46,000
+70.4%
10,7660.0%0.00%
Q4 2016$27,000
+3.8%
10,7660.0%0.00%
Q3 2016$26,0000.0%10,7660.0%0.00%
Q2 2016$26,000
-10.3%
10,7660.0%0.00%
Q1 2016$29,000
-46.3%
10,766
-12.2%
0.00%
-100.0%
Q1 2015$54,000
+10.2%
12,266
+19.5%
0.00%0.0%
Q4 2014$49,00010,2660.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
EAM Investors, LLC 129,929$603,0000.19%
ABNER HERRMAN & BROCK LLC 56,050$260,0000.06%
CFO4Life Group, LLC 12,000$56,0000.03%
Spark Investment Management LLC 12,000$55,0000.03%
Phoenix Holdings Ltd. 118,533$534,0000.03%
HighPoint Advisor Group LLC 13,533$82,0000.02%
GSA CAPITAL PARTNERS LLP 12,500$58,0000.02%
ETF MANAGERS GROUP, LLC 66,197$299,0000.01%
WINTON GROUP Ltd 76,967$357,0000.01%
IHT Wealth Management, LLC 13,000$60,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders